![Bedrijf uit Retie dat polsbandjes maakt neemt labelspecialist Eurotag over (Retie) | Het Nieuwsblad Mobile Bedrijf uit Retie dat polsbandjes maakt neemt labelspecialist Eurotag over (Retie) | Het Nieuwsblad Mobile](https://static.nieuwsblad.be/Assets/Images_Upload/2021/02/06/0de2dfba-b586-4b42-98a5-1d4494c5d6ab.jpg)
Bedrijf uit Retie dat polsbandjes maakt neemt labelspecialist Eurotag over (Retie) | Het Nieuwsblad Mobile
![Role of IGF-I in Primary Ovarian Cancer – A Study of the OVCAD European Consortium | Anticancer Research Role of IGF-I in Primary Ovarian Cancer – A Study of the OVCAD European Consortium | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/36/3/1015/F2.large.jpg)
Role of IGF-I in Primary Ovarian Cancer – A Study of the OVCAD European Consortium | Anticancer Research
![Cancer surveillance in healthy carriers of germline pathogenic variants in BRCA1/2 : a review of secondary prevention guidelines Cancer surveillance in healthy carriers of germline pathogenic variants in BRCA1/2 : a review of secondary prevention guidelines](https://biblio.ugent.be/publication/8700748/file/8720439/thumbnail.png)
Cancer surveillance in healthy carriers of germline pathogenic variants in BRCA1/2 : a review of secondary prevention guidelines
![Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer | npj Genomic Medicine Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer | npj Genomic Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41525-022-00300-5/MediaObjects/41525_2022_300_Fig1_HTML.png)
Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer | npj Genomic Medicine
![2022-RA-1263-ESGO Phase II randomized BGOG-CX3 trial comparing atezolizumab in combination with doxorubicin versus doxorubicin alone in second-line or later recurrent cervical cancer | International Journal of Gynecologic Cancer 2022-RA-1263-ESGO Phase II randomized BGOG-CX3 trial comparing atezolizumab in combination with doxorubicin versus doxorubicin alone in second-line or later recurrent cervical cancer | International Journal of Gynecologic Cancer](https://ijgc.bmj.com/content/ijgc/32/Suppl_2/A51.1/F1.large.jpg)
2022-RA-1263-ESGO Phase II randomized BGOG-CX3 trial comparing atezolizumab in combination with doxorubicin versus doxorubicin alone in second-line or later recurrent cervical cancer | International Journal of Gynecologic Cancer
Vlaams Belang - Hassan Iasir, één van de moordenaars van agente Kitty Van Nieuwenhuysen, mag de gevangenis verlaten en thuis zitten met een enkelband. In 2011 krijgt deze moordenaar 30 jaar cel
How to Select Neoadjuvant Chemotherapy or Primary Debulking Surgery in Patients With Stage IIIC or IV Ovarian Carcinoma | Journal of Clinical Oncology
![Predictive value of the Leuven HRD test compared with Myriad myChoice PLUS on 468 ovarian cancer samples from the PAOLA-1/ENGOT-ov25 trial (LBA 6) - ScienceDirect Predictive value of the Leuven HRD test compared with Myriad myChoice PLUS on 468 ovarian cancer samples from the PAOLA-1/ENGOT-ov25 trial (LBA 6) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090825822012999-fx1.jpg)
Predictive value of the Leuven HRD test compared with Myriad myChoice PLUS on 468 ovarian cancer samples from the PAOLA-1/ENGOT-ov25 trial (LBA 6) - ScienceDirect
![Els NIEUWENHUYSEN | Universitair Ziekenhuis Leuven, Leuven | UZ Leuven | Department of Gynaecology and obstetrics | Research profile Els NIEUWENHUYSEN | Universitair Ziekenhuis Leuven, Leuven | UZ Leuven | Department of Gynaecology and obstetrics | Research profile](https://www.researchgate.net/publication/328882995/figure/fig1/AS:692130011947012@1542028062900/Schematic-overview-of-study-design-Abbreviations-BW-birth-weight-BMI-body-mass_Q320.jpg)